Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , Anxiety/complications , Panic Disorder/diagnosis , Panic Disorder/drug therapy , Paroxetine/therapeutic use , Adult , Antipsychotic Agents/therapeutic use , Combined Modality Therapy , Humans , Male , Middle Aged , Panic Disorder/complications , Psychotherapy , Treatment OutcomeABSTRACT
Depressive state in cancer patients is known to meet the criteria of mild depressive episode (F33.0) according to ICD-10. In the earlier stages of the disease and after successful treatment, depressive symptoms are usually combined with anxiety and obsessive fear, moderate appearances of ideator and motor inhibition, with permanent presence of asthenic symptoms. Once the disease is getting severer and the treatment is less successful, asthenia acquires hyposthenic features, with symptoms of apathy and dysphoria being attached. Cypramil was shown to be an effective medication in the treatment of depression in patients with malignant tumors of gastric-intestinal tract. The most efficient was the treatment conducted on the earlier stages of the cancer process and in cases of successful surgery and chemotherapy, in combination of depression with anxiety, anxious hypochondria, asthenia. Antidepressants must be used together with psychotherapy.
Subject(s)
Citalopram/therapeutic use , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/etiology , Gastrointestinal Neoplasms/psychology , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Citalopram/administration & dosage , Depressive Disorder, Major/diagnosis , Drug Administration Schedule , Female , Humans , Male , Middle Aged , Selective Serotonin Reuptake Inhibitors/administration & dosage , Severity of Illness IndexSubject(s)
Agoraphobia/complications , Agoraphobia/drug therapy , Anti-Anxiety Agents/therapeutic use , Benzodiazepines/therapeutic use , Panic Disorder/complications , Adult , Agoraphobia/diagnosis , Agoraphobia/psychology , Alprazolam/therapeutic use , Humans , Middle Aged , Military Personnel/psychology , Panic Disorder/diagnosis , Panic Disorder/drug therapy , RussiaABSTRACT
Thirty one patients, aged 23-48 years, with ICD-10 diagnosis of psychogenic neurotic depression (F32.0 and F32.1), were studied. According to antidepressants used, the patients were divided into 2 groups, of which the test one included 19 patients treated by cipramil (20-40 mg/day) and the comparative one consisted of 12 patients treated with amitriptilin (25-50 mg/day). The treatment duration was 28 days. The patient's state was evaluated, using clinical approach and instrumental methods, i.e. Hamilton depression scale, before treatment and on 14th and 28th days. After cipramil treatment, 14 patients out of 19 exhibited an improvement, with 5 revealing neurotic symptoms compensation. However, 5 patients proved to be resistant to the medication. In amitriptilin treatment, complete depression reduction was found only in 1 patient, with pronounced improvement being shown in 8 out of 12 patients. No changes in the patient's state were revealed for 3 cases. Cipramil treatment was not accompanied with any side effects.
